default author photo

Koichi Fukunaga

Keio University - Division of Pulmonary Medicine

Tokyo

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

162

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Randomised Controlled Trial of a Novel Digital Therapy for Smoking Cessation

Number of pages: 33 Posted: 01 Oct 2019
Keio University - Division of Pulmonary Medicine, Keio University - Division of Pulmonary Medicine, CureApp, Inc. - CureApp Institute, CureApp, Inc. - CureApp Institute, CureApp, Inc., CureApp, Inc. - CureApp Institute, The University of Osaka - Department of Biostatistics and Data Science and Keio University - Division of Pulmonary Medicine
Downloads 90 (747,755)

Abstract:

Loading...

2.

Pro108Ser mutant of SARS-CoV-2 3CL pro Reduces the Enzymatic Activity and Ameliorates COVID-19 Severity in Japan

Number of pages: 25 Posted: 30 Dec 2020
Keio University - Department of Surgery, Keio University - Department of Biochemistry, Osaka University - Department of Biotechnology, Keio University - Department of Molecular Biology, Keio University - Department of Molecular Biology, Keio University - Division of Infection Diseases and Infection Control, Keio University - Department of Pediatrics, Keio University - Department of Infectious Diseases, Keio University - School of Medicine, Osaka University - Department of Biotechnology, U-Medico, Inc., Keio University - Department of Laboratory Medicine, Keio University, School of Medicine, Center for Infectious Diseases and Infection Control, Keio University - Division of Gene Regulation, Keio University - Department of Surgery, Keio University - Division of Pulmonary Medicine, Keio University - Department of Dermatology, Keio University - Department of Molecular Biology, Keio University - Department of Biochemistry, Keio University - Center for Medical Genetics and Independent
Downloads 72 (867,774)

Abstract:

Loading...

SARS-CoV-2, COVID-19, non-synonymous mutation, 3CLpro, Pro108Ser